南京科佰生物科技有限公司官方網站歡迎您的光臨!
免費咨詢熱線: 4008-750-250
科研細胞
藥靶細胞
標準品
AI-Edigene? EML4(E18)-ALK (E20) v2 Fusion
CBP20196R |
Format | RNA |
Description | EML4-ALK results from the fusion of EML4 and ALK, resulting in constitutive kinase activity, transformation in cultured cells, and tumor activity in mouse models (PMID: 19064915, PMID: 17625570). EML4-ALK fusions have been associated with non-small cell lung cancer (PMID: 26755435). |
Technical Data | |
Left Gene | EML4 |
Left Breakpoint | chr2:42543844:+ |
Right Gene | ALK |
Right Breakpoint | chr2:29446566:- |
Buffer | RNase-free H2O |
Product Information | |
Intended Use | Research Use Only |
Unit Size | 1ug |
Concentration | Download for COA |
Purity | Download for COA |
RNA electrophoresis | Download for COA |
Sanger sequencing | Download for COA |
Storage | -80℃ |
Expiry | 12 months from the date of manufacture |

掃一掃,關注我們公眾號
Copyright ?2021 www.ventura-flowers.com All Rights Reserved. 南京科佰生物科技有限公司版權所有 蘇ICP備13038923號